LEO, Eliana Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.424
AS - Asia 9.248
EU - Europa 8.302
SA - Sud America 1.326
AF - Africa 200
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 16
Totale 36.568
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.061
SG - Singapore 2.683
GB - Regno Unito 2.586
CN - Cina 2.527
IT - Italia 1.889
HK - Hong Kong 1.064
VN - Vietnam 1.064
SE - Svezia 1.039
BR - Brasile 1.029
DE - Germania 637
BD - Bangladesh 396
FR - Francia 371
UA - Ucraina 361
FI - Finlandia 360
RU - Federazione Russa 351
KR - Corea 308
TR - Turchia 278
IN - India 260
CA - Canada 179
BG - Bulgaria 151
AR - Argentina 114
NL - Olanda 106
ID - Indonesia 99
MX - Messico 91
JP - Giappone 84
BE - Belgio 77
IQ - Iraq 70
ZA - Sudafrica 61
PL - Polonia 55
ES - Italia 51
PK - Pakistan 47
AE - Emirati Arabi Uniti 46
IR - Iran 44
EC - Ecuador 42
IE - Irlanda 41
CO - Colombia 39
PH - Filippine 39
AU - Australia 37
CL - Cile 34
LT - Lituania 34
MA - Marocco 32
RO - Romania 28
MY - Malesia 25
CH - Svizzera 24
CZ - Repubblica Ceca 24
TW - Taiwan 23
UZ - Uzbekistan 23
KE - Kenya 22
VE - Venezuela 22
EG - Egitto 21
PY - Paraguay 19
TH - Thailandia 19
TN - Tunisia 19
AZ - Azerbaigian 17
JM - Giamaica 17
JO - Giordania 17
NP - Nepal 17
SA - Arabia Saudita 16
IL - Israele 15
PT - Portogallo 15
AT - Austria 14
NZ - Nuova Zelanda 14
PA - Panama 14
DZ - Algeria 13
PE - Perù 13
GR - Grecia 12
CR - Costa Rica 11
EU - Europa 10
KZ - Kazakistan 10
RS - Serbia 10
DK - Danimarca 9
HU - Ungheria 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
AL - Albania 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
LK - Sri Lanka 7
PS - Palestinian Territory 7
BY - Bielorussia 6
EE - Estonia 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
BO - Bolivia 5
ET - Etiopia 5
GE - Georgia 5
KG - Kirghizistan 5
PR - Porto Rico 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
HN - Honduras 4
HR - Croazia 4
KW - Kuwait 4
MN - Mongolia 4
NG - Nigeria 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
Totale 36.510
Salva come PNG Salva come JPEG
Città #
Southend 1.754
Singapore 1.730
Santa Clara 1.715
Ashburn 1.546
Fairfield 1.243
Chandler 1.067
Hong Kong 1.034
Woodbridge 944
Hefei 798
Jacksonville 711
Houston 691
San Jose 656
Dearborn 572
Nyköping 523
Ann Arbor 521
Wilmington 506
Beijing 480
Seattle 469
Cambridge 429
London 370
Los Angeles 350
Ho Chi Minh City 338
Chicago 333
Council Bluffs 297
Modena 282
Hanoi 271
Seoul 269
The Dalles 248
Helsinki 225
New York 198
Milan 162
Izmir 152
Princeton 149
Sofia 141
Lauterbourg 127
Eugene 126
Salt Lake City 122
San Diego 119
Buffalo 109
Moscow 109
Dallas 100
Bremen 94
Shanghai 85
São Paulo 81
Rome 75
Redwood City 73
Frankfurt am Main 70
Tampa 63
Columbus 62
Da Nang 61
Fremont 61
Munich 59
Tokyo 58
Orem 57
Brussels 55
Des Moines 51
Bologna 48
Elk Grove Village 46
Jakarta 45
Warsaw 43
Ottawa 36
Guangzhou 35
Dublin 34
Mexico City 34
Atlanta 33
Rio de Janeiro 33
Washington 33
Boardman 32
Mumbai 32
Chennai 31
Falls Church 31
Haiphong 31
Lancaster 31
Montreal 31
Toronto 31
Amsterdam 30
Denver 30
Johannesburg 30
Naples 30
San Francisco 30
Nanjing 29
Phoenix 28
Belo Horizonte 27
Brooklyn 25
Kent 25
Miami 25
New Delhi 25
Baghdad 24
Formigine 24
Miano 24
Parma 23
Porto Alegre 23
Kunming 22
San Mateo 22
Dhaka 21
Detroit 20
Napoli 20
Tashkent 20
Basingstoke 19
Quito 19
Totale 24.276
Salva come PNG Salva come JPEG
Nome #
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 467
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 459
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 433
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 413
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 400
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 398
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 381
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 380
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 379
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 375
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 375
Bead coating process via an excess of crosslinking agent 362
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 355
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 354
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 352
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 351
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 350
Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector 346
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 343
Chitosan-alginate microparticles as a protein carrier 341
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 340
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 337
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 334
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 333
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 332
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 329
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 320
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 320
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 314
Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier 313
In vivo detection of lipid-based nano- and microparticles in the outermost human stratum corneum by EDX analysis 310
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 309
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 304
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 301
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 300
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 297
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 296
Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles 294
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 292
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 288
PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. 286
Vettori particellari per il rilascio sito-specifico di farmaci nel tratto gastro-intestinale 285
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation 285
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 284
In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form 280
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 280
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 280
Protein immobilization in crosslinked alginate microparticles 277
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 272
Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method 272
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 271
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 271
A hydroxypropylcellulose (HPC) system for the immediate and controlled release of diclofenac sodium 270
Cell internalization study of hybrid chitosan-heparin-PLGA nanocarriers on Caco-2 cells 269
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 266
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 265
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 259
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 258
Oral tolerance elicited in mice by b-lactoglobulin entrapped in biodegradable microspheres. 253
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 253
Drug delivery strategies of Geraniol via nose-to-brain for the treatment of neuronal disorders 253
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 251
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 250
PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated 249
Caratterizzazione chimico-fisica di membrane e feltri di collagene 249
Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates 247
Preparation and characterization of biodegradable nanoparticles containing a lipophilic drug in water-soluble or insoluble form 243
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 243
Formulazione e caratterizzazione di nanoparticelle polimeriche per la somministrazione orale di eparina 243
Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates 242
Cationic solid lipid nanoparticles containing Protamine as transfection vector on neuroblastoma cell line 240
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 240
Intact collagen and atelocollagen sponges: Characterization and ESEM observation 237
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 236
Studio reologico del complesso alginato/chitosano/albumina per la preparazione di microsfere 236
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 235
Modified PLGA Nanoparticles as drug carriers for CNS delivery 232
Surface drug removal from ibuprofen-loaded PLA microspheres 232
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 231
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 227
In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time 226
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 226
Polymeric nanoparticles as drug controlled release systems: A new formulation strategy for drugs with small or large molecular weight 225
A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres 224
Veicolazione intracellualre di DNA plasmidico mediante solid lipid nanoparticles (SLN) cationiche 223
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 223
Caratterizzazione chimico-fisica e studi di stabilità di sistemi lipidici per il transfer genico 222
In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin 221
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 218
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 217
In vitro behaviour of multicomposite cationic SLN as new platform for pDNA delivery 215
Studio della fotodegradazione di un complesso PABA/alginato per la formulazione di filtri solari 213
Sistemi lipidici per il transfer genico: sintesi di nuove molecole per la progettazione di vettori sintetici efficaci 212
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 212
Development of new formulations of cationic solid lipid nanoparticles (SLNs) for the drug delivery to the brain 211
Formulazione per veicolare principi attivi lipofili 210
The influence of 2-hydroxypropyl-beta-cyclodextrin on the haemolysis induced by bile acids 205
Ovuli vaginali a rilascio prolungato come inquinanti in pap-test 202
Drug release from perforated matrices containing hydroxypropylcellulose 202
In vitro behaviour of N6-cyclopentyladenosine-loaded nanoparticles prepared via a non-aqueous nanoprecipitation method 197
Totale 28.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.585 63 304 233 158 86 174 125 134 314 196 510 288
2022/20232.985 464 350 212 326 337 419 56 243 332 48 113 85
2023/20241.624 77 117 129 161 340 176 161 160 46 38 78 141
2024/20256.582 272 71 187 432 1.203 796 543 499 670 243 748 918
2025/202612.085 780 504 949 1.330 1.828 809 1.491 676 1.297 1.218 655 548
2026/2027288 288 0 0 0 0 0 0 0 0 0 0 0
Totale 36.865